Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity ofhVEGF (10 ng/mL), a concentration of 0.05 - 0.1 μg/mL of this antibody is required. ELISA: Indirect: To detect hVEGF by indirect ELISA (using 100 μL/well antibody solution) aconcentration of 0.5 - 2.0 μg/mL of this antibody is required. This antigen affinity purifiedantibody, in conjunction with compatible secondary reagents, allows the detection of atleast 0.2 - 0.4 ng/well of recombinant hVEGF. Sandwich: To detect hVEGF by sandwich ELISA (using 100 μL/well antibody solution) aconcentration of 0.5 - 2.0 μg/mL of this antibody is required. This antigen affinity purifiedantibody, in conjunction Biotinylated Anti-Human VEGF as a detection antibody, allows thedetection of at least 0.2 - 0.4 ng/well of recombinant hVEGF. Western Blot: To detect hVEGF by Western Blot analysis this antibody can be used at aconcentration of 0.1 - 0.2 μg/mL. Used in conjunction with compatible secondary reagentsthe detection limit for recombinant hVEGF is 1.5 - 3.0 ng/lane, under either reducing ornon-reducing conditions. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Rekonstitution
Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
Buffer
Lyophilized from PBS, pH 7.2, None
Handhabung
This product is photosensitive and should be protected from light. Should it contain a precipitate we recommend microcentrifugation before use.
Lagerung
4 °C
Informationen zur Lagerung
Store the antibody undiluted at 2-8 °C. DO NOT FREEZE!
Target
VEGFA
(Vascular Endothelial Growth Factor A (VEGFA))